HealthHundreds Sue GLP-1 Makers Over Alleged Vision-Loss Warning Failures

Hundreds of Americans are suing Novo Nordisk and Eli Lilly, alleging they were not adequately warned that GLP-1 drugs could pose a risk of vision loss. Novo Nordisk says it is vigorously defending the cases and calls them without merit, while Eli Lilly says patient safety is its top priority.